Implantable Device Pricing, Utilization Are Under GAO's Microscope
This article was originally published in The Gray Sheet
Executive Summary
The Government Accountability Office is investigating the pricing and utilization of implantable medical devices at the request of Senate Finance Committee Chairman Max Baucus, D-Mont
You may also be interested in...
Sen. Baucus, Key Architect Of Device Tax, Health Reform, To Retire In 2014
Sen. Max Baucus, D-Mont., chairman of the powerful Senate Finance Committee, and one of the key architects of the Affordable Care Act and device tax, says he will serve out his term, but not seek re-election in November 2014.
GAO Report Renews Debate Over Device Price Confidentiality
Hospitals, group purchasing organizations and other health care stakeholders want Congress to do away with pricing confidentiality clauses in purchase contracts for implantable devices, but industry wants to maintain its ability to keep device prices secret.
GAO Report Renews Debate Over Device Price Confidentiality
Hospitals, group purchasing organizations and other health care stakeholders want Congress to do away with pricing confidentiality clauses in purchase contracts for implantable devices, but industry wants to maintain its ability to keep device prices secret.